Enter a job title or keyword

Regulatory Officer

PSI CRO


Job Location:

Belgrade - Serbia

Monthly Salary: Not provided by the employer
Posted: 29 September 2026 (6 hours ago)
Application Deadline: 27 December 2026
Vacancies: 1 Vacancy

Job Summary

Join our team of experts in regulatory and ethics submissions of clinical studies.  You will focus on facilitating the start of research projects of novel medicinal products while taking a step further in your professional career.

Office-based position

Your role:

  • Prepare clinical trial submission dossiers for Regulatory and Ethics Authorities including Import and Export license applications
  • Communicate with regulatory authorities ethics committees project teams and vendors on regulatory-related matters
  • Review translations of essential documents subject to clinical trial submission
  • Track the regulatory project documentation flow
  • Review documents to greenlight IP release to sites
  • Manage safety reporting to authorities
  • Deliver regulatory training to project teams
  • Assist with feasibility research and business development requests

Qualifications :

 

  • College/University degree or an equivalent combination of education training and experience
  • Prior experience with clinical trial submissions is required 
  • Full working proficiency in English and Serbian
  • Proficiency in MS Office applications
  • Detail-oriented
  • Ability to learn plan and work in a dynamic team environment
  • Communication collaboration and problem-solving skills

Additional Information :

We are currently looking for a knowledgeable self-motivated and proactive person to join our Regulatory Affairs Department at PSI Serbia.


Remote Work :

No


Employment Type :

Full-time


About Company

Company Logo

PSI is a leading full-service global Contract Research Organization whose key strength is predictable patient enrollment across multiple therapeutic areas. PSI is known in the industry as a CRO focused on ‘on-time project delivery’. This is achieved through investing substantial effo ... View more

View Profile View Profile